Volition says lung cancer study supports Nu.Q assay, targets France reimbursement

The company said clinical certification at Hospices Civils de Lyon is complete and expects a reimbursement dossier under France’s RIHN framework in the coming months.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.